Medical Technology company Inogen Inc (NASDAQ:INGN) reported a fourth-quarter adjusted EPS loss of 24 cents, compared to a loss of 83 cents a year ago, beating the consensus loss of 61 cents. The ...

BEVERLY, Mass.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the ...

Welcome to Inogen’s Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session.

Revenue exceeded expectations with a 3.34% positive surprise. EPS missed forecasts, contributing to a 1.27% decline in stock price post-earnings. International sales grew significantly, offsetting ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid second-quarter 2024 ...